title: Studies in the modulation of experimental autoimmune encephalomyelitis.
abstract: Experimental autoimmune encephalomyelitis (EAE), an experimental model for multiple sclerosis, can be induced through inoculation with several different central nervous system (CNS) proteins or peptides. Modulation of EAE, resulting in either protection from EAE or enhancement of EAE, can also be accomplished through either vaccination or DNA immunization with molecular mimics of self-CNS proteins. Previously published data on this method of EAE modulation will be reviewed. New data is presented, which demonstrates that EAE can also be modulated through the administration of the beta-(1,3)-D-glucan, curdlan. Dendritic cells stimulated by curdlan are involved in the differentiation of the interleukin-17 producing subset of CD4(+) T cells that are recognized effector cells in EAE. Using two different systems to study the effects of curdlan on EAE, it was found that curdlan increased the incidence of EAE and/or the severity of the disease course.
authors.affiliation: Department of Pathology, University of Utah School of Medicine, 30 North 1900 East, 3R330 SOM, Salt Lake City, UT 84132, USA.
authors.forename: Jane E
authors.initials: JE
authors.lastname: Libbey
authors.forename: Ikuo
authors.initials: I
authors.lastname: Tsunoda
authors.forename: Robert S
authors.initials: RS
authors.lastname: Fujinami
mesh_terms: D000818:Animals; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009479:Neuropeptides / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use; D047071:beta-Glucans / Q000494:pharmacology
chemical_list: D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D018696:Neuroprotective Agents; D047071:beta-Glucans; C038459:curdlan
references.citation: Int Rev Neurobiol. 2007;79:73-97
references.pmid: 17531838
references.citation: J Neuroimmunol. 2008 Nov 15;204(1-2):92-100
references.pmid: 18706703
references.citation: Curr Med Chem. 2008;15(19):1899-910
references.pmid: 18691047
references.citation: J Neuroimmunol. 1997 May;75(1-2):75-83
references.pmid: 9143240
references.citation: J Immunol. 2001 Jun 15;166(12):7579-87
references.pmid: 11390514
references.citation: Curr Opin Microbiol. 1999 Aug;2(4):392-7
references.pmid: 10458987
references.citation: Chem Immunol. 1989;46:101-25
references.pmid: 2482036
references.citation: Nihon Rinsho Meneki Gakkai Kaishi. 2009 Feb;32(1):20-8
references.pmid: 19252374
references.citation: J Neuropathol Exp Neurol. 1996 Jun;55(6):673-86
references.pmid: 8642393
references.citation: Immunity. 2001 Jul;15(1):15-22
references.pmid: 11485734
references.citation: J Immunol. 1999 Mar 15;162(6):3336-41
references.pmid: 10092787
references.citation: J Immunol. 1994 Nov 15;153(10):4349-56
references.pmid: 7525700
references.citation: J Neuroimmunol. 1993 Apr;44(1):15-25
references.pmid: 7684398
references.citation: Autoimmunity. 2006 Feb;39(1):9-19
references.pmid: 16455578
references.citation: J Neuroimmunol. 2007 Aug;188(1-2):22-33
references.pmid: 17604850
references.citation: J Exp Med. 2001 Sep 3;194(5):669-76
references.pmid: 11535634
references.citation: Ann N Y Acad Sci. 2007 Apr;1103:157-66
references.pmid: 17376824
references.citation: Brain Pathol. 2007 Apr;17(2):219-29
references.pmid: 17388953
references.citation: J Autoimmun. 2001 May;16(3):229-34
references.pmid: 11334487
references.citation: J Exp Med. 2005 Jan 17;201(2):233-40
references.pmid: 15657292
references.citation: Curr Top Microbiol Immunol. 2006;311:117-53
references.pmid: 17048707
references.citation: J Immunol. 2007 Feb 1;178(3):1372-8
references.pmid: 17237384
references.citation: Nat Immunol. 2009 Feb;10(2):203-13
references.pmid: 19122653
references.citation: J Neuropathol Exp Neurol. 1998 Aug;57(8):758-67
references.pmid: 9720491
references.citation: J Neuroimmunol. 1999 May 3;96(2):148-57
references.pmid: 10337913
references.citation: Ann N Y Acad Sci. 2008 Nov;1143:35-44
references.pmid: 19076343
references.citation: Curr Drug Targets Inflamm Allergy. 2005 Apr;4(2):239-45
references.pmid: 15853746
references.citation: Immunol Rev. 2006 Jun;211:164-81
references.pmid: 16824126
references.citation: J Neurovirol. 2001 Jun;7(3):220-7
references.pmid: 11517396
references.citation: Neurochem Res. 1994 Aug;19(8):915-21
references.pmid: 7528354
references.citation: Nat Immunol. 2007 Jun;8(6):630-8
references.pmid: 17450144
references.citation: Recent Pat Biotechnol. 2007;1(1):59-73
references.pmid: 19075833
references.citation: Nat Immunol. 2006 Nov;7(11):1151-6
references.pmid: 16998492
references.citation: Nature. 1986 Nov 20-26;324(6094):258-60
references.pmid: 2431317
references.citation: Int Immunopharmacol. 2009 May;9(5):575-81
references.pmid: 19539560
references.citation: Allergol Int. 2008 Jun;57(2):115-20
references.pmid: 18427164
references.citation: J Exp Med. 2005 Mar 21;201(6):949-60
references.pmid: 15781585
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):876-81
references.pmid: 19136631
references.citation: Semin Immunol. 2004 Oct;16(5):335-47
references.pmid: 15528078
references.citation: Appl Microbiol Biotechnol. 2005 Aug;68(2):163-73
references.pmid: 15818477
references.citation: J Exp Med. 2005 Feb 21;201(4):523-33
references.pmid: 15710651
references.citation: J Neuroimmunol. 1996 Feb;64(2):163-73
references.pmid: 8632058
references.citation: Neurochem Res. 1994 Aug;19(8):935-44
references.pmid: 7528355
references.citation: Results Probl Cell Differ. 2010;51:21-42
references.pmid: 19130026